EU-funded R&D project
Atrial Fibrillation Integrated Approach
Atrial fibrillation (AF) is an irregular and often very rapid heart rhythm (arrhythmia) that can lead to blood clots in the heart. AF increases the risk of stroke, heart failure and other heart-related complications. The prevalence of AF is growing amongst Europe’s elderly population, often facing multimorbidity. The management of AF therefore requires a holistic approach rather than a single-disease approach with fragmented care.
AAFFIRMO aims to move from fragmentation to an integrated care strategy designed to be patient-centred. AFFIRMO’s care pathway will improve the clinical management of older AF patients, taking into account personal treatment preferences, social context, polypharmacy etc. It will enable synergies and cooperation among the different health disciplines involved, and shared decision-making with the patient. AFFIRMO’s care pathway will rely on a digital platform develop to assist physicians in applying and tailoring a personalised care strategy.
i~HD is a consortium partner and handles all legal and ethical challenges. This involves leading work on information governance, GDPR compliance and data sharing.
AFFIRMO has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 899871. It started on 1 May 2021 and will end on 30 April 2026.
Aalborg Universitet, Advice Pharma Group srl, Arrhythmia Alliance, Consiglio Nazionale delle Ricerche, European Union Geriatric Medicine Society aisbl, The European Institute for Innovation through Health Data, Faculty of Medicine – University of Belgrade, Fondazione per il Tuo Cuore Onlus, Istituto Superiore di Sanita, Karolinska Institutet, Meditcinsky Universitet-Plovdiv, Moverim Consulting sprl, Ontonix srl, The University of Liverpool, Universiteit Gent, Universitatea de Medicina si Farmacie Carol Davila din Bucuresti, Universita Degli Studi di Padova, Universita Cattolica del Sacro Cuore, The University of Manchester, Universidad de Murcia